Pharmaceuticals in India
SummaryPharmaceuticals in India industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Indian pharmaceuticals market had total revenues of $32,500.0m in 2019, representing a compound annual growth rate (CAGR) of 2.2% between 2015 and 2019.
- The Indian market is growing, driven by an increase in real GDP, doctors and India’s population covered by insurance. A number of major government initiatives are set to support this growth in the future
- The Indian market supplies around 40% of generic demand in the US and 25% of all medicine in the UK. Around 80% of the world’s antiretroviral drugs used in the treatment of HIV/AIDs are made in India.
Scope
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in India
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in India
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the India pharmaceuticals market with five year forecasts
Reasons to Buy
- What was the size of the India pharmaceuticals market by value in 2019?
- What will be the size of the India pharmaceuticals market in 2024?
- What factors are affecting the strength of competition in the India pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitiors in India's pharmaceuticals market?
MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.
For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.
MarketLine’ holistic business intelligence report collection includes:
Industry Intelligence
‒ Industry Profiles
‒ Market Forecasts
‒ Porter’s Five Forces Analysis
Company Intelligence
‒ Company Profiles
‒ SWOT Analysis
‒ Financial Deals
Country and City Intelligence
‒ Country and City Profiles
‒ PEST/PESTLE Analysis
‒ Socio and macro-economic indicators
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.